Literature DB >> 6167351

Lack of effective messenger RNA for beta 2-microglobulin in a gestational human choriocarcinoma cell line (GCH-1).

K Tanaka, Y Nabeshima, H Takahashi, S Takeuchi, Y Nabeshima, K Ogata.   

Abstract

When two lines of gestational human choriocarcinoma cells (GCH-1 and GCH-2) were incubated with [35S]methionine, the labeled beta 2-microglobulin was not detected on sodium dodecyl sulfate:polyacrylamide gel electrophoresis after purification of the labeled protein with affinity chromatography, using rabbit antibody against beta 2-microglobulin as the ligand. In contrast, in the case of nongestational choriocarcinoma cells originating from male stomach cells, the incorporation of [35S]methionine into beta 2-microglobulin was observed. When polyadenylate-containing messenger RNA prepared from GCH-1 cells was incubated with [35S]methionine in a rabbit reticulocyte lysate system, the labeling of beta 2-microglobulin was not shown. On the other hand, when polyadenylate-containing messenger RNA from nongestational choriocarcinoma cells was incubated in the same cell-free system, labeled beta 2-microglobulin was detected. These results indicate that beta 2-microglobulin is not synthesized in gestational human choriocarcinoma cells and at least in the case of GCH-1, beta 2-microglobulin is not synthesized owing to the lack of effective messenger RNA for beta 2-microglobulin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167351

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Primary non-gestational pure choriocarcinoma arising in the ovary: A case report and literature review.

Authors:  Shinichi Hayashi; Yoshiro Abe; Shigeki Tomita; Yuko Nakanishi; Shigeharu Miwa; Takahiko Nakajima; Kazuhiro Nomoto; Koichi Tsuneyama; Takahiro Fujimori; Johji Imura
Journal:  Oncol Lett       Date:  2015-02-26       Impact factor: 2.967

2.  An immunohistological study of HLA antigen expression by gestational choriocarcinoma.

Authors:  C A Sunderland; M Sasagawa; K Kanazawa; G M Stirrat; S Takeuchi
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.